Differential contribution of the mitochondrial translation pathway to the survival of diffuse large B-cell lymphoma subsets

Cell Death and Differentiation

Volumn 24, Issue 2, 2017, Pages 251-262

  Norberg, Erik ^a,e   Lako, Ana ^a   Chen, Pei Hsuan ^a   Stanley, Illana A ^a   Zhou, Feng ^a,b   Ficarro, Scott B ^a,b   Chapuy, Bjoern ^b   Chen, Linfeng ^b   Rodig, Scott ^c   Shin, Donghyuk ^d   Choi, Dong Wook ^a   Lee, Sangho ^d   Shipp, Margaret A ^b   Marto, Jarrod A ^a,b,c   Danial, Nika N ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Sungkyunkwan University   (South Korea)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; MITOCHONDRIAL DNA; TIGECYCLINE; ACETYLCYSTEINE; ANTIINFECTIVE AGENT; ELONGATION FACTOR G; ELONGATION FACTOR TU; GFM1 PROTEIN, HUMAN; LYMPHOCYTE ANTIGEN RECEPTOR; MITOCHONDRIAL PROTEIN; MRPS7 PROTEIN, HUMAN; MULTIENZYME COMPLEX; REACTIVE OXYGEN METABOLITE; RIBOSOME PROTEIN; SMALL INTERFERING RNA; TUFM PROTEIN, HUMAN;

ARTICLE; ASSAY; CANCER SURVIVAL; CONTROLLED STUDY; DIFFUSE LARGE B CELL LYMPHOMA; DNA SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MASS SPECTROMETRY; MITOCHONDRIAL ENERGY TRANSFER; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RESPIRATORY CHAIN; ANTAGONISTS AND INHIBITORS; CELL SURVIVAL; DRUG EFFECTS; GENETICS; METABOLISM; MITOCHONDRION; PATHOLOGY; PROTEIN MOTIF; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE;

ACETYLCYSTEINE; AMINO ACID MOTIFS; ANTI-BACTERIAL AGENTS; CELL SURVIVAL; ELECTRON TRANSPORT CHAIN COMPLEX PROTEINS; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; OXIDATIVE PHOSPHORYLATION; PEPTIDE ELONGATION FACTOR G; PEPTIDE ELONGATION FACTOR TU; REACTIVE OXYGEN SPECIES; RECEPTORS, ANTIGEN, B-CELL; RIBOSOMAL PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 84992021883     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2016.116     Document Type: Article

References (60)

1. Metallo CM, Vander Heiden MG. Understanding metabolic regulation and its influence on cell physiology. Mol Cell 2013; 49: 388-398.
2. Stanley IA, Ribeiro SM, Gimenez-Cassina A, Norberg E, Danial NN. Changing appetites: the adaptive advantages of fuel choice. Trends Cell Biol 2014; 24: 118-127.
3. Boroughs LK, DeBerardinis RJ. Metabolic pathways promoting cancer cell survival and growth. Nat Cell Biol 2015; 17: 351-359.
4. DeNicola GM, Cantley LC. Cancer's fuel choice: new flavors for a picky eater. Mol Cell 2015; 60: 514-523.
5. Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 2011; 27: 441-464.
6. Koppenol WH, Bounds PL, Dang CV. Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 2011; 11: 325-337.
7. Caro P, Kishan AU, Norberg E, Stanley IA, Chapuy B, Ficarro SB et al. Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma. Cancer Cell 2012; 22: 547-560.
8. Mashimo T, Pichumani K, Vemireddy V, Hatanpaa KJ, Singh DK, Sirasanagandla S et al. Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. Cell 2014; 159: 1603-1614.
9. Obre E, Rossignol R. Emerging concepts in bioenergetics and cancer research: Metabolic flexibility, coupling, symbiosis, switch, oxidative tumors, metabolic remodeling, signaling and bioenergetic therapy. Int J Biochem Cell Biol 2015; 59C: 167-181.
10. Schug ZT, Peck B, Jones DT, Zhang Q, Grosskurth S, Alam IS et al. Acetyl-CoA Synthetase 2 Promotes Acetate Utilization and Maintains Cancer Cell Growth under Metabolic Stress. Cancer Cell 2015; 27: 57-71.
11. Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, Lopez M et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci USA 2010; 107: 8788-8793.
12. Yuneva MO, Fan TW, Allen TD, Higashi RM, Ferraris DV, Tsukamoto T et al. The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Cell Metab 2012; 15: 157-170.
13. Wright G, Tan B, Rosenwald A, Hurt EH, Wiestner A, Staudt LM. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci USA 2003; 100: 9991-9996.
14. Monti S, Savage KJ, Kutok JL, Feuerhake F, Kurtin P, Mihm M et al. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 2005; 105: 1851-1861.
15. Monti S, Chapuy B, Takeyama K, Rodig SJ, Hao Y, Yeda KT et al. Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma. Cancer Cell 2012; 22: 359-372.
16. Chen L, Monti S, Juszczynski P, Ouyang J, Chapuy B, Neuberg D et al. SYK inhibition modulates distinct PI3K/AKT-dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomas. Cancer Cell 2013; 23: 826-838.
17. Pfeifer M, Grau M, Lenze D, Wenzel SS, Wolf A, Wollert-Wulf B et al. PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma. Proc Natl Acad Sci USA 2013; 110: 12420-12425.
18. Gustafsson CM, Falkenberg M, Larsson NG. Maintenance and Expression of Mammalian Mitochondrial DNA. Annu Rev Biochem 2016; 85: 133-160.
19. Rebelo AP, Dillon LM, Moraes CT, Mitochondrial DNA. transcription regulation and nucleoid organization. J Inherit Metab Dis 2011; 34: 941-951.
20. Ott M, Amunts A, Brown A. Organization and Regulation of Mitochondrial Protein Synthesis. Annu Rev Biochem 2016; 85: 77-101.
21. Shahni R, Wedatilake Y, Cleary MA, Lindley KJ, Sibson KR, Rahman S. A distinct mitochondrial myopathy, lactic acidosis and sideroblastic anemia (MLASA) phenotype associates with YARS2 mutations. Am J Med Genet A 2013; 161: 2334-2338.
22. Baker MJ, Tatsuta T, Langer T. Quality control of mitochondrial proteostasis. Cold Spring Harb Perspect Biol 2011; 3: a00755.
23. Enriquez JA. Supramolecular organization of respiratory complexes. Annu Rev Physiol 2016; 78: 533-561.
24. Zhou F, Lu Y, Ficarro SB, Webber JT, Marto JA. Nanoflow low pressure high peak capacity single dimension LC-MS/MS platform for high-throughput, in-depth analysis of mammalian proteomes. Anal Chem 2012; 84: 5133-5139.
25. Zhou F, Lu Y, Ficarro SB, Adelmant G, Jiang W, Luckey CJ et al. Genome-scale proteome quantification by DEEP SEQ mass spectrometry. Nat Commun 2013; 4: 2171.
26. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503-511.
27. Polo JM, Juszczynski P, Monti S, Cerchietti L, Ye K, Greally JM et al. Transcriptional signature with differential expression of BCL6 target genes accurately identifies BCL6-dependent diffuse large B cell lymphomas. Proc Natl Acad Sci USA 2007; 104: 3207-3212.
28. Bestwick ML, Shadel GS. Accessorizing the human mitochondrial transcription machinery. Trends Biochem Sci 2013; 38: 283-291.
29. Echevarria L, Clemente P, Hernandez-Sierra R, Gallardo ME, Fernandez-Moreno MA, Garesse R. Glutamyl-tRNAGln amidotransferase is essential for mammalian mitochondrial translation in vivo. Biochem J 2014; 460: 91-101.
30. Rorbach J, Richter R, Wessels HJ, Wydro M, Pekalski M, Farhoud M et al. The human mitochondrial ribosome recycling factor is essential for cell viability. Nucleic Acids Res 2008; 36: 5787-5799.
31. Jenner L, Starosta AL, Terry DS, Mikolajka A, Filonava L, Yusupov M et al. Structural basis for potent inhibitory activity of the antibiotic tigecycline during protein synthesis. Proc Natl Acad Sci USA 2013; 110: 3812-3816.
32. Muralidharan G, Micalizzi M, Speth J, Raible D, Troy S. Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects. Antimicrob Agents Chemother 2005; 49: 220-229.
33. Wenzel R, Bate G, Kirkpatrick P. Tigecycline. Nat Rev Drug Discov 2005; 4: 809-810.
34. Skrtic M, Sriskanthadevan S, Jhas B, Gebbia M, Wang X, Wang Z et al. Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia. Cancer Cell 2011; 20: 674-688.
35. Acin-Perez R, Bayona-Bafaluy MP, Fernandez-Silva P, Moreno-Loshuertos R, Perez-Martos A, Bruno C et al. Respiratory complex III is required to maintain complex I in mammalian mitochondria. Mol Cell 2004; 13: 805-815.
36. Diaz F, Fukui H, Garcia S, Moraes CT. Cytochrome c oxidase is required for the assembly/stability of respiratory complex I in mouse fibroblasts. Mol Cell Biol 2006; 26: 4872-4881.
37. Schagger H, de Coo R, Bauer MF, Hofmann S, Godinot C, Brandt U. Significance of respirasomes for the assembly/stability of human respiratory chain complex I. J Biol Chem 2004; 279: 36349-36353.
38. Maranzana E, Barbero G, Falasca AI, Lenaz G, Genova ML. Mitochondrial respiratory supercomplex association limits production of reactive oxygen species from complex I. Antioxid Redox Signal 2013; 19: 1469-1480.
39. Dranka BP, Hill BG, Darley-Usmar VM. Mitochondrial reserve capacity in endothelial cells: The impact of nitric oxide and reactive oxygen species. Free Radic Biol Med 2010; 48: 905-914.
40. Nicholls DG. Spare respiratory capacity, oxidative stress and excitotoxicity. Biochem Soc Trans 2009; 37: 1385-1388.
41. Orrenius S, Gogvadze V, Zhivotovsky B. Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol 2007; 47: 143-183.
42. Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr Biol 2014; 24: R453-R462.
43. Brand MD. Mitochondrial generation of superoxide and hydrogen peroxide as the source of mitochondrial redox signaling. Free Radic Biol Med 2016 (e-pub ahead of print 13 April 2016; doi: 10.1016/j.freeradbiomed.2016.04.001).
44. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 2009; 417: 1-13.
45. Nagar H, Jung SB, Kwon SK, Park JB, Shong M, Song HJ et al. CRIF1 deficiency induces p66shc-mediated oxidative stress and endothelial activation. PLoS One 2014; 9: e98670.
46. Schedlbauer A, Kaminishi T, Ochoa-Lizarralde B, Dhimole N, Zhou S, Lopez-Alonso JP et al. Structural characterization of an alternative mode of tigecycline binding to the bacterial ribosome. Antimicrob Agents Chemother 2015; 59: 2849-2854.
47. Amunts A, Brown A, Toots J, Scheres SH, Ramakrishnan V. Ribosome. The structure of the human mitochondrial ribosome. Science 2015; 348: 95-98.
48. Scarpulla RC, Vega RB, Kelly DP. Transcriptional integration of mitochondrial biogenesis. Trends Endocrinol Metab 2012; 23: 459-466.
49. Sotgia F, Whitaker-Menezes D, Martinez-Outschoorn UE, Salem AF, Tsirigos A, Lamb R et al. Mitochondria "fuel" breast cancer metabolism: fifteen markers of mitochondrial biogenesis label epithelial cancer cells, but are excluded from adjacent stromal cells. Cell Cycle 2012; 11: 4390-4401.
50. Friedberg JW, Sharman J, Sweetenham J, Johnston PB, Vose JM, Lacasce A et al. Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia. Blood 2010; 115: 2578-2585.
51. Younes A, Thieblemont C, Morschhauser F, Flinn I, Friedberg JW, Amorim S et al. Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study. Lancet Oncol 2014; 15: 1019-1026.
52. Corazao-Rozas P, Guerreschi P, Jendoubi M, Andre F, Jonneaux A, Scalbert C et al. Mitochondrial oxidative stress is the Achille's heel of melanoma cells resistant to Braf-mutant inhibitor. Oncotarget 2013; 4: 1986-1998.
53. Viale A, Pettazzoni P, Lyssiotis CA, Ying H, Sanchez N, Marchesini M et al. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature 2014; 514: 628-632.
54. Bucaneve G, Micozzi A, Picardi M, Ballanti S, Cascavilla N, Salutari P et al. Results of a multicenter, controlled, randomized clinical trial evaluating the combination of piperacillin/tazobactam and tigecycline in high-risk hematologic patients with cancer with febrile neutropenia. J Clin Oncol 2014; 32: 1463-1471.
55. Chen L, Monti S, Juszczynski P, Daley J, Chen W, Witzig TE et al. SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma. Blood 2008; 111: 2230-2237.
56. Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB et al. Chronic active B-cellreceptor signalling in diffuse large B-cell lymphoma. Nature 2010; 463: 88-92.
57. Askenazi M, Parikh JR, Marto JA. mzAPI: a new strategy for efficiently sharing mass spectrometry data. Nat Methods 2009; 6: 240-241.
58. Parikh JR, Askenazi M, Ficarro SB, Cashorali T, Webber JT, Blank NC et al. multiplierz: an extensible API based desktop environment for proteomics data analysis. BMC Bioinformatics 2009; 10: 364.
59. Jitkova Y, Gronda M, Hurren R, Wang X, Goard CA, Jhas B et al. A novel formulation of tigecycline has enhanced stability and sustained antibacterial and antileukemic activity. PLoS One 2014; 9: e95281.
60. Acin-Perez R, Fernandez-Silva P, Peleato ML, Perez-Martos A, Enriquez JA. Respiratory active mitochondrial supercomplexes. Mol Cell 2008; 32: 529-539.